Sann-Joong-Kuey-Jian-Tang inhibits hepatocellular carcinoma Hep-G2 cell proliferation by increasing TNF-α, Caspase-8, Caspase- 3 and Bax but by decreasing TCTP and Mcl-1 expression in vitro

Molecular Medicine Reports

Volumn 7, Issue 5, 2013, Pages 1487-1493

  Chen, Yao Li ^a   Yan, Meng Yi ^a   Chien, Su Yu ^a   Kuo, Shou Jen ^a   Chen, Dar Ren ^a   Cheng, Chun Yuan ^a   Su, Chin Cheng ^a,b  

^a CHANGHUA CHRISTIAN HOSPITAL   (Taiwan)

^b CHINA MEDICAL UNIVERSITY   (Taiwan)

Author keywords

Apoptosis; Hep G2 cells; Sann Joong Kuey Jian Tang; TCTP; TNF

Indexed keywords

CASPASE 3; CASPASE 8; CHINESE DRUG; HERBACEOUS AGENT; PROTEIN BAX; PROTEIN MCL 1; SANN JOONG KUEY JIAN TANG; TRANSLATIONALLY CONTROLLED TUMOR PROTEIN; TUMOR NECROSIS FACTOR ALPHA; TUMOR PROTEIN; UNCLASSIFIED DRUG;

ANTINEOPLASTIC ACTIVITY; ARTICLE; CELL PROLIFERATION; CELL STRAIN HEPG2; HUMAN; HUMAN CELL; IC 50; IMMUNOCYTOCHEMISTRY; IMMUNOFLUORESCENCE; IN VITRO STUDY; LIVER CELL CARCINOMA; PROTEIN EXPRESSION; WESTERN BLOTTING;

ANTIGENS, CD95; APOPTOSIS; BCL-2-ASSOCIATED X PROTEIN; CARCINOMA, HEPATOCELLULAR; CASPASE 3; CASPASE 8; CASPASES; CELL CYCLE; CELL DEATH; CELL PROLIFERATION; CELL SURVIVAL; DRUG SCREENING ASSAYS, ANTITUMOR; DRUGS, CHINESE HERBAL; FAS-ASSOCIATED DEATH DOMAIN PROTEIN; HEP G2 CELLS; HUMANS; IMMUNOHISTOCHEMISTRY; LIVER NEOPLASMS; PROTO-ONCOGENE PROTEINS C-BCL-2; TUMOR MARKERS, BIOLOGICAL; TUMOR NECROSIS FACTOR-ALPHA;

CITRUS MACROPHYLLA;

EID: 84876009557     PISSN: 17912997     EISSN: 17913004     Source Type: Journal    
DOI: 10.3892/mmr.2013.1381     Document Type: Article

References (14)

1. Jemal A, Bray F, Center MM, Ferlay J, Ward E and Forman D: Global cancer statistics. CA Cancer J Clin 61: 69-90, 2011.
2. Statistics of Causes of Death, 2010. Department of Health, Executive Yuan, Taipei, Taiwan, R.O.C, p153, 2012.
3. Leung TW and Johnson PJ: Systemic therapy for hepatocellular carcinoma. Semin Oncol 28: 514-520, 2001.
4. Hsu YL, Yen MH, Kuo PL, et al: San-Zhong-Kui-Jian-Tang, a traditional Chinese medicine prescription, inhibits the proliferation of human breast cancer cells by blocking cell cycle progression and inducing apoptosis. Biol Pharm Bull 29: 2388-2394, 2006.
5. Cheng CY, Lin YH and Su CC: Sann-Joong-Kuey-Jian-Tang increases the protein expression of microtubule-associated protein II light chain 3 in human colon cancer colo 205 cells. Mol Med Rep 2: 707-711, 2009.
6. Cheng CY, Lin YH and Su CC: Sann-Joong-Kuey-Jian-Tang up-regulates the protein expression of Fas and TNF-α in colo 205 cells in vivo and in vitro. Mol Med Rep 3: 63-67, 2010.
7. Cohen GM: Caspases, the executioners of apoptosis. Biochem J 326: 1-16, 1997
8. L Lowe SW, Cepero E and Evan G: Intrinsic tumour suppression. Nature 432: 307-315, 2004.
9. Carswell EA, Old LJ, Kassel RL, et al: An endotoxin-induced serum factor that causes necrosis of tumors. Proc Natl Acad Sci USA 72: 3666-3670, 1975.
10. Gaur U and Aggarwal BB: Regulation of proliferation, survival and apoptosis by members of the TNF superfamily. Biochem Pharmacol 66: 1403-1408, 2003.
11. Graidist P, Phongdara A and Fujise K: Antiapoptotic protein partners fortilin and MCL1 independently protect cells from 5-fluorouracil-induced cytotoxicity. J Biol Chem 279: 40868-40875, 2004.
12. Liu H, Peng HW, Cheng YS, et al: Stabilization and enhancement of the antiapoptotic activity of mcl-1 by TCTP. Mol Cell Biol 25: 3117-3126, 2005.
13. Zhang D, Li F, Weidner D, et al: Physical and functional interaction between myeloid cell leukemia 1 protein (MCL1) and Fortilin. The potential role of MCL1 as a fortilin chaperone. J Biol Chem 277: 37430-37438, 2002.
14. Susini L, Besse S, Duflaut D, et al: TCTP protects from apoptotic cell death by antagonizing bax function. Cell Death Differ 15: 1211-1220, 2008.